Moderna and Merck are celebrating a major milestone after their personalized mRNA cancer treatment succeeded in a late-stage trials.
Moderna’s Cancer Vaccine Breakthrough Sends Stocks Soaring
calendar_today
August 21, 2026
domain
cheddar